ESC 365 - Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial

ESC Professional Premium Access

Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial

Session: Practical dilemmas in atrial fibrillation therapies

Topic: Rhythm Control, Cardioversion

Speaker: Professor M. Rienstra (Groningen, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Michiel Rienstra

University Medical Centre Groningen, Groningen (Netherlands (The))

15 presentations

4 followers

3 more presentations in this session

State-of-the art lecture on practical dilemmas in atrial fibrillation therapies

Speaker: Professor J. Camm (London, GB)

Postoperative atrial fibrillation following noncardiac surgery is associated with long-term heart failure: insights from a nationwide cohort

Speaker: Ms M. Karacan (Copenhagen, DK)

Strategy optimization for the combined procedure of left atrial appendage occlusion plus catheter ablation in patients with atrial fibrillation (COMBINATION): a multi-center, randomized study

Speaker: Doctor X. Du (Ningbo, CN)

Access the full session

Practical dilemmas in atrial fibrillation therapies

Speakers: Professor M. Rienstra, Professor J. Camm, Ms M. Karacan, Doctor X. Du

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources